AK-Pentolate en es it fr

AK-Pentolate Brand names, AK-Pentolate Analogs

AK-Pentolate Brand Names Mixture

  • No information avaliable

AK-Pentolate Chemical_Formula


AK-Pentolate RX_link

No information avaliable

AK-Pentolate fda sheet

AK-Pentolate msds (material safety sheet)

AK-Pentolate MSDS

AK-Pentolate Synthesis Reference

No information avaliable

AK-Pentolate Molecular Weight

291.385 g/mol

AK-Pentolate Melting Point

139 oC (hydrochloride salt)

AK-Pentolate H2O Solubility

No information avaliable

AK-Pentolate State


AK-Pentolate LogP


AK-Pentolate Dosage Forms

Ophthalmic solution (eye drops)

AK-Pentolate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

AK-Pentolate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

AK-Pentolate Absorption

Absorbed following ophthalmic administration.

AK-Pentolate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

AK-Pentolate Patient Information

No information avaliable

AK-Pentolate Organisms Affected

Humans and other mammals